PDCD1 and neoplasm: The combination of PD-1 with its ligand, the programmed cell death protein ligand 1 (PD-L1), which expresses on cancer cells in the tumor microenvironment (TME), will pass on regulatory signals to effector T cells causing T cell exhaustion and antiapoptotic signals to tumor cells resulting in tumor survival, hence severely suppressing the immune response.